Wolverine BPC-157 / TB-500 — Tissue Repair Research
Wolverine names a BPC-157 / TB-500 combination associated with tissue-repair research. The blend ratio and exact TB-500 identity must be confirmed; human healing benefits are not established for this product.
Wolverine BPC-157 / TB-500 — Tissue Repair Research
This listing represents the BPC-157 / TB-500 combination supplied under the name Wolverine. Research discussions often focus on tissue responses and repair pathways, but evidence for individual compounds cannot establish the safety or effectiveness of this specific combination.
At a glance
- Listed components: BPC-157 and TB-500, subject to supplier verification.
- Primary focus: tissue-repair research, not a promised injury-recovery outcome.
- Exact TB-500 identity matters; do not assume equivalence to full-length thymosin beta-4 or transfer its findings automatically.
Evidence and intended use
Claims of faster healing, tendon repair, pain relief, or recovery from injury are not established for this blend. FDA identifies safety concerns for BPC-157 and thymosin beta-4 fragment products.
Common question
Does combining the ingredients prove better recovery?
No. A blend requires evidence for its own formulation; combining two research compounds does not establish added benefit or safety.
Product details
Confirm the exact formulation, strength, package size, and intended use against the supplier label. Refer to the manufacturer documentation for storage and handling information.
| Compound class | Peptide blend — ratio unconfirmed |
|---|---|
| Primary focus | Tissue repair research |
| Size | 10MG |
